Biogen Inc. buy Royal Bank of Canada
Start price
31.07.23
/
50%
€245.60
Target price
31.07.24
€339.11
Performance (%)
-19.97%
End price
01.08.24
€196.55
Summary
This prediction ended on 01.08.24 with a price of €196.55. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.97%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -0.045% | -0.045% | -39.361% |
| iShares Core DAX® | -0.933% | 0.936% | 37.129% |
| iShares Nasdaq 100 | -2.152% | 3.580% | 21.416% |
| iShares Nikkei 225® | 0.021% | 1.387% | 12.234% |
| iShares S&P 500 | -2.296% | 2.847% | 14.854% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $379.00 to $374.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten